granulocytes & t-cells as biomarkers for relapse in cml following discontinuation of tkis
Published 10 months ago • 72 plays • Length 3:18Download video MP4
Download video MP3
Similar videos
-
1:17
targeting persisting stem cells in search for a novel cml treatment
-
3:34
effect of time to relapse on os in mcl following autohct
-
1:47
state of the art in cml
-
3:27
allogeneic hemopoietic stem cell transplants for advanced phase cml
-
0:38
the functional role of cd4- and cd8-expressing t-cells in aml
-
32:11
cell cycle cancer biology, chemotherapy, cml, and familial syndromes, [molecular biology 9 of 11]
-
48:39
clonal expansion of blood stem cells in aging and leukemia with leonard zon
-
1:36:57
mapping the new era in cll management with precision medicine
-
4:27
cml management in resource limited countries
-
1:28
the role of allogeneic transplantation in patients with aml in the frontline setting
-
1:49
targeting leukemic stem cells in aml
-
0:53
the importance of using novel strategies to target leukemic stem cells more effectively
-
1:21
the role of transplant in the era of new treatments for lymphoma and cll
-
1:23
indications for autologous stem cell transplantation in aml
-
0:57
characteristics and clinical implications of leukemic stem cells
-
3:05
diagnosis and management of cmml
-
8:57
outcomes of sct in t-all and t-lbl
-
0:54
the role of allogeneic stem cell transplantation in cll
-
9:26
understanding the evolution from haematopoietic stem cell to leukemic cell
-
2:11
the current role of immuno-oncology in aml and future outlooks
-
2:33
dli following haplohct ptcy relapse
-
1:56
investigating linvoseltamab monotherapy in smm: the linker-smm1 trial